Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors
US9163040B2 · kind B2 · utility
0Cited by
24References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2014 |
| Grant date | Oct 20, 2015 |
| Priority date | — |
| Expiry date | Feb 12, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65515
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula I;or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.